| From : | Gregg Alton <Gregg.Alton@gilead.com> |
| To : | Averhoff; Francisco (CDC/OID/NCHHSTP) <fma0@cdc.gov>; Graeme Robertson <Graeme.Robertson@gilead.com> |
| Subject : | Oversight Committee Call/Agenda |
| Cc : | Diana Brainard <Diana.Brainard@gilead.com>; Ruth Diazaraque-Marin <Ruth.Diazaraque-Marin@gilead.com>; Christina Carlson <Christina.Carlson@gilead.com>; Ward; John (CDC/OID/NCHHSTP) <jww4@cdc.gov>; David Sergeenko;Valeri (Georgia) <v.kvaratskhelia@outlook.com>; valeri <vkvaratskhelia@moh.gov.ge> |
| Received On : | 22.06.2016 23:54 |
| Attachments : |
Attached please find a draft agenda for the oversight committee meeting schedule for June 30. Please review and let me know if you have any changes, additions or questions.
I look forward to the meeting.
Thank you,
Gregg
Gregg Alton
Executive Vice President, Commercial and Access Operations ALA, Corporate and Medical Affairs
Gilead Sciences, Inc.
333 Lakeside Drive, Foster City, CA 94404
(650) 522-5783 (phone)
(650) 522-5537 (private fax)
This email message is for the sole use of the intended recipient(s) and may contain confidential and
privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message.